Movatterモバイル変換


[0]ホーム

URL:


MXPA96002029A - Containers for liqui medicines - Google Patents

Containers for liqui medicines

Info

Publication number
MXPA96002029A
MXPA96002029AMXPA/A/1996/002029AMX9602029AMXPA96002029AMX PA96002029 AMXPA96002029 AMX PA96002029AMX 9602029 AMX9602029 AMX 9602029AMX PA96002029 AMXPA96002029 AMX PA96002029A
Authority
MX
Mexico
Prior art keywords
container
mixing element
container according
suspension
mixing
Prior art date
Application number
MXPA/A/1996/002029A
Other languages
Spanish (es)
Other versions
MX9602029A (en
Inventor
Micheler Clemens
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9511169.6Aexternal-prioritypatent/GB9511169D0/en
Application filed by Eli Lilly And CompanyfiledCriticalEli Lilly And Company
Publication of MXPA96002029ApublicationCriticalpatent/MXPA96002029A/en
Publication of MX9602029ApublicationCriticalpatent/MX9602029A/en

Links

Abstract

The present invention relates to a container for a suspension of liquid medicament, characterized in that it has a piston operable therein and an outlet thereof, and because it contains a solid mixing element, wherein the mixing element and the inner surface of the Container are configured to cooperate and constrain the mixing element against significant lateral movement, but allow axial movement, the mixing element is configured to allow suspension flow from either side of the element to the other when moving the axial element.

Description

:CONTAINERS FOR LIQUID MEDICINESFIELD OF THE INVENTIONThis invention relates to containers for liquid medicaments, especially for suspensions of liquid medicament, ie for formulations having liquid and particulate solid components in which at least one of the components, usually at least the solid component, has medicinal or medicinal properties .
BACKGROUND OF THE INVENTIONIt is known how to provide containers for liquid medicaments, for example solutions and suspensions, wherein the container takes the form of a cartridge or ampule formed from a tube, suitably, of glass sealed at one end by a piston and ending at the other end in an outlet piece sealed by a lid. In use, the cartridge is placed in a device similar to a ballpoint pen provided with a mechanism that operates by means of a piston. This mechanism, when operated, serves to move the piston a predetermined distance along the tube of the cartridge to inject a dose of the liquid medicament through a hypodermic needle, which is attached to the end of the cap so as to pierce the cover and establish communication with the inside of the cartridge. The volume of the cartridge is usually sufficient to accommodate various doses of medication, and the mechanism operated by the piston allows individual doses to be administered in controlled amounts and predetermined by the user or the patient. Even the multi-day supply of medication may be present in the cartridge. Such a pen-like device and multi-dose cartridges are described in European Patent Application 0058536. They are especially suitable for use with insulin formulations, and diabetic patients appreciate its convenience. To make sure that exact doses of those cartridges and pen devices are administered, the cartridge, whether containing a suspension or solution, should be free of any gas bubbles, although a small gas bubble or air bag may be present. present initially and be removed before the administration of the first dose by holding the device with the needle pointing upwards and then squeezing any gas by using the mechanism operated by the piston. Instructions on the needle and how to do this are usually included in the patient information leaflets that accompany the refilled cartridges. In the case of suspensions of liquid medication, however, the absence of an air gap or gas bubble of any significant size can make it difficult or fully consume the resuspended suspension in time, which will settle over time as the The cartridge / pen remains unused, for example in the patient's pocket or handbag, or during the storage of the cartridge before being loaded into the pen. Resuspension before injection is, of course, essential if the correct dose of the active ingredient, usually the solid component, is to be administered, and a failure in the total resuspension can have dangerous consequences, for example the case of suspensions. of insulin can lead to coma and other complications that endanger life. It is known to include in such medicament suspension cartridges one or more mixed elements, for example as taught in European Patent Application 0235691. The commercialized versions, which contain suspensions of insulin crystals, include one or more glass or metal spheres which, when the cartridge is shaken or inverted several times, are free to move and move within the cartridge, thus facilitating the mixing or homogenization of the suspension. Similarly, devices for the controlled infusion of medicaments are known. For example, U.S. Patent Application No. 4568335 describes a device that has a container for a suspension of medicament., a piston movable along the container, and an outlet piece connected by means of a tube to a hypodermic needle at an infusion site. It is taught that the mixing of the suspension is facilitated by the inclusion of an air bag or a small steel sphere within the container / suspension, air bag or sphere which can be made to move by spinning and inverting the end container to extreme several times before the infusion of each dose, the action is described as essential for the safe and effective operation of the device. Again, those devices are described as particularly suitable for the administration of a variable range of insulin suspension formulations, either commercially available or spontaneously blended with the faster acting forms in solution. The present invention also seeks to address the problem of adequately and rapidly resuspending suspensions of liquid medicament in containers such as those described above, furthermore it seeks to provide a container that allows an even faster or more reliable mixing, or with less agitation than required for the mixing elements used and described above.
BRIEF DESCRIPTION OF THE INVENTIONThus, in accordance with the present invention, there is provided a container for a suspension of liquid medicament, for example of the type described above, having a piston operable therein and an outlet therefrom, and containing a solid mixing element. , characterized in that the mixing element and the internal surface of the container are shaped to cooperate and restrict the mixing element against significant lateral movement but allow axial movement, the mixing element is shaped to allow the flow of the suspensions on either side from the element to the other side as the element moves axially, for example by tilting or inverting the container from end to end. The mixing element is solid since, in spite of an air bubble, the element has a fixed self-deformed external shape; however, as mentioned below, the mixing element may be hollow. The mixing element can be shaped to have a continuous or discontinuous peripheral surface cooperating with the internal surface of the container. The element can be shaped to present and define a plurality of angularly spaced regions, for example surfaces or points or contact lines to cooperate with the internal surface of the container. The general, and as preferred, the container and its internal surface should be cylindrical and the total cross section of the mixing element should be circular, ie the radially outermost parts of the element will be on a circle. Other corresponding forms of cooperation are possible for containers of different cross sectional shape.
The significant restriction against lateral movement of the mixing element within the container is suitably achieved by sizing the mixing element appropriately so that it is in a tight fit but slides freely within the container. Some lateral movement is tolerable, but should not be so large as to allow the mixing element to move significantly out of the axial alignment with the container with the undesirable result that the element is free to jump and rotate as long as the The container is inclined or inverted or, in fact, tilts by itself out of alignment with the wall of the container and therefore runs the risk of being trapped or squeezed into the container so that its mixing function is compromised. The mixing element may, however, be free to rotate axially and may be properly shaped to promote or reduce such rotary movement as it slidably moves within the container. This is an important difference between the mixing element employed in the present invention and the mixing elements proposed and used in the prior art, ie the movement of the element within the container is mainly a sliding movement along the length of the container (optionally with the axial rotary action), instead of being primarily a rolling or tumbling action as in the prior art. In addition, and as preferred, the mixing element of the present invention extends, at least in part, through essentially the entire diameter of the container, with the result that a greater proportion of the cross-section of the container is subject to the action of sweeping and mixing the element as it moves from one end of the container to the other. The shaping of the mixing element, to allow the flow of the suspension from one side to the other, appropriately takes the form of one or more openings through the element or, additionally or alternatively, one or more passages defined by the mixing element in combination with the internal surface of the container, such as by cavities or channels formed in the periphery of the mixing element. These openings, cavities or channels can, if desired, be profiled, for example with projections or constructions, to increase turbulence in the suspension as it flows from either side of the mixing element to another, and / or can be angularly placed in relation to the axis of the mixing element and in relation to its direction of travel to impart an axial rotational movement to the element as it moves axially within the container. Additionally or alternatively, the mixing element can be provided with blades, for example radially placed blades, angled with respect to the axis of movement of the element. The blades may all be angled in the same orientation, to make or promote the mixing element to develop a rotational movement as it moves axially within the container, or it may be arranged in opposite orientation to increase the turbulence in the medium flow of suspension as it flows between the blades. Where the mixing element is driven to move axially within the container by the simple action of tilting or end-to-end inversion of the latter, the material of which the element is made should have a density sufficiently different from that of the suspension medium, preferably at least a difference of 10%, more preferably at least a difference of 50% and more preferably at least a difference of 100%, to allow the element to fall or rise as the container is manipulated . Suitable materials that are more dense include metals, such as stainless steel, ceramics, certain plastics and glass, especially sintered glass. Materials less dense than the suspension medium, and which could float therein, include, for example, certain foamed plastics. Alternatively, the mixing element can be hollow and filled with gas, for example air, and therefore reach to float in the suspension medium. In addition, the mixing element can be formed or have implanted thereon a magnetic or magnetically sensitive material so that the axial movement of the element is caused and controlled by the movement of a corresponding magnetic device external to the container, such as a slidable collar, for example, it forms part of any body similar to a ballpoint pen in which the container in use is housed. Where the mixing element is magnetic or magnetically sensitive, its total density is less relevant. However, the material from which the element is made, or at least that part in contact with the suspension medium, must, however, be pharmaceutically acceptable, that is, it must not be toxic and inert to the components of the suspension.
The material from which the body is formed is preferably glass, although other pharmaceutically acceptable materials include metals, such as aluminum, rigid plastic materials and ceramics.
BRIEF DESCRIPTION OF THE DRAWINGSThe invention can be carried out in several ways, and now only several specific embodiments with possible modifications will be described by way of example, with reference to the accompanying drawings, in which: Figure 1 is a perspective view of a cylindrical cartridge or ampule for a suspension of liquid medicament and constructed in accordance with the invention; Figure 1A is a section of a part of the outlet of the cartridge of Figure 1; Figure 2 is a view from the end of the mixing element; Figure 3 is a section through the mixing element of Figure 2;Figure 4 is a perspective view of the mixing element of Figure 2; Figures 5 to 10 are views from the end of several mixing elements shaped differently; Figures 5A to 10A are respective sections on lines 5-5, 6-6, 7-7, 8-8, 9-9 and 10-10 of Figures 5 to 10; Figures 11 and 12 are perspective views of additional different mixing elements; Figures 13 and 13A are views from the end and in perspective, respectively, of another element; Figure 14 is an end view of a modified version of the element shown in Figures 13 and 13A; Figures 15 and 15A are views from the end and in perspective, respectively, of an additional element; and Figures 16 and 17 are perspective views of additional elements.
DETAILED DESCRIPTION OF THE INVENTIONReferring to Figures 1 to 4, a container in the form of a single-compartment cartridge or bullet 10 comprises a cylindrical glass tube with an open end 11 which has a neck of reduced diameter 12 at one end and which is sealed in the other end by means of a synthetic rubber piston 13 having, for example, three annular edges 14 engaging the inner surface of the tube 11. The cartridge 10 is filled with a suspension of liquid medicament, for example an aqueous suspension of insulin such as insulin isofane (NPH), and is free of air bubbles. The neck 12 is closed by an aluminum lid with an opening 16 and a synthetic rubber membrane or septum 17. When the cartridge 10 is loaded in one of the commercially available pen-like devices and a hypodermic needle is mounted, the needle perforates the membrane or septum 17, thereby entering and communicating with the interior of the cartridge 10. A mixing element 20 is located in the container and moves axially in the tube 11 between the inner end 21 of the piston 13 and a flange 22 at the inner end of the neck 12 of the outlet. The element 20 is shaped to cooperate with the inner surface 15 of the tube 11, which has three angularly spaced surfaces 31 which conform closely to the surface 15. The element 20 is sized to be in a narrow but non-restricted sliding fit. the tube 11 (see especially Figure 2), being therefore restricted against significant lateral movement. The mixing element 20 is free to rotate about the axis of the tube 11, but the lack of significant lateral movement prevents the element from rotating around any other axis so that it is not free to rotate or jump along the tube 11. , neither to tilt and be tightened in the tube 11. The mixing element 20 is also shaped to allow the flow of the medication suspension from one side to the other having an opening 34 extending therethrough, there are also passages 33. which extend from one side to the other of the element 20, defined and formed by three recesses 32 on the element 20 in combination with the surface 15 of the tube 11. Any of the opening 34 or the passages 33 could be omitted, but if it is preferred to have at least one internal passage, for example central, and an external one, for example peripheral, to increase the turbulence produced in the suspension by the movement of the mixing element 20 along the tube 11, since it is the turbulence produced in the flow of the suspension medium which is mainly responsible for the stirring action necessary to resuspend the particles in suspension leading to the desired homogenization of the drug. Element 20 in this mode is made of sintered glass, specifically Type I glass(pharmaceutical specification), such as that supplied by Schott Glasswerke, Mainz, Germany, under the trademark "FIOLAX". By tilting the tube 11 (for example when it is loaded in the pen-like housing) so that its axis is at an angle of 45 ° with respect to the horizontal, the mixing element 20 moves inside the tube 11 under the gravity and because its density is greater than that of the aqueous suspension, it is guided in its movement by the inner surface of the tube 15 in three angularly separated places defined by the three peripheral portions 31. In an example, of a container with a capacity of 3.0 cm3 with a total length of 6.5 cm, wherein the inner surface 15 has a diameter of 9.5 mm, the portions 31 are on a diameter of 9 mm, the recesses 32 have a length of 5.88 mm, the axial length of the element 20 is 4 mm and the diameter of the opening 34 is 3 mm. As with the variations in the measurements given above, other variations in the construction of the mixing element 20 are possible, of course. For example, the peripheral portions may vary in angular degree and may also vary in number. For example, there could be 2, 4, 5 or 6 or more peripheral portions separated by recesses. Alternatively, the periphery of the mixing element could have a completely continuous surface, the passages (32) would therefore be omitted. Similarly, mixing elements with openings (34) of different sizes, and in shapes other than circular, can be provided. Also, instead of a single opening, there may be a plurality of openings extending through the element (20), in fact, there may be an absence of an opening, provided the passages (32) are present to allow the flow of the suspension from either side of the element (20) to the other. Other variations include providing transverse edges or corrugations on the recesses 32 or on the wall of the openings 34 to increase the turbulence in the flow of the suspension medium. In addition, the diameter of the openings (34) may vary along the axial axis thereof, again to promote a greater turbulent flow in the suspension medium. For example the openings could be used from one axial end to the other, and where there are, for example, two openings or more, the direction of the lift can be reversed between the different openings. Also, any tapering inward opening from each axial end to a minimum cross section can be constructed, say halfway along the element. Those variations of the different characteristics of the mixing element can, of course, be made independently of the other characteristics. For example, the variations described above with respect to the openings are equally applicable to the mixing elements having different peripheral shapes, for example as described below. A selection of other examples of mixing elements is shown in Figures 5 to 10. In Figures 5 and 5A, the mixing element 40 has a single central opening 34 and eight angularly spaced peripheral portions 31 present on the radially placed teeth 41. having flat sides 42, the angle between the adjacent sides 42 of the nearby tooth is 60 °. In a specific example, the surface portions 31 are of a diameter of 9.3 mm, for use in a cartridge with an internal diameter of 9.5 mm. In Figures 6 and 6A, the mixing element 43 is similar to the mixing element 40 but has two openings of equal size 44, each 2 mm in diameter. The mixing element, shown in theFigures 7 and 7A are provided with 4 channels or generally rectangular grooves 45 equiangularly spaced around the periphery and which, when the element is located inside a cylindrical container serve to define, with the surface of the inner wall of the container, the passages to allow the flow of the suspension from either side of the element to the other. Between the channels or grooves 45 there are four equiangular peripheral portions with angled surfaces to cooperate with the inner surface of the container. Typically, the channels or grooves are 1 mm deep. The element is also shown with a single central opening, but which can be omitted or replaced by two or more openings.
The element 46 in Figures 8 and 8A is similar to that of Figures 7 and 7A, but the channels are more numerous and each extends over a larger radial arc, with the result that the peripheral portions take the shape of teeth radially placed 47. The element 46 has a single central opening therethrough. The mixing element of Figures 9 and 9A is similar to 1 of Figures 8 and 8A, but is provided with two openings 44. Alth those openings are shown to have straight perforations, the perforations may, as described above, be tapered, either in the same or opposite directions. The mixing element illustrated in Figures 10 and 10A present three angularly spaced surfaces to cooperate with the inner surface of a tubular shaped container, similarly to the surfaces 31 of the mixing element 20 shown in Figures 1 to 4 but a instead of being separated by recesses, the cooperating surfaces are separated by circular peripheral cuts in part 48, for example of radius 1.5 mm. The mixing element 50 shown in Figure 11, alth having a plurality of peripheral surfaces to cooperate with the internal surface of a cylindrical cartridge, has deep grooves 51 cut in the periphery and running parallel to the axis of the element and its direction of travel . Figure 12 shows a similar mixing element but where the grooves, alth individually straight, are inclined towards the central axis of the element and its direction of displacement to induce the rotary movement towards the element as it moves axially inside the cartridge and through the suspension. This rotational movement is a feature of the examples of mixing elements shown in Figures 13 to 15A. The mixing elements of Figures 13 and 14 are of a cup or plate shape in general, having a base portion 60 and an edge representing a peripheral outer continuous surface 61 for cooperating with the inner surface of a cartridge container cylindrical. The angularly spaced portions are removed from the base 60 to provide openings therein, and internal and external radial grooves 63, 64 are cut into the base to allow the portions 65 to be brought in from the plane of the base 60. The degree The angle of the portions 65 may vary, as can the number of such portions -see Figure 14- as well as the angle at which the portions are bent from the plane of the base 60. The base 60 is connected to a tube axial 66, which defines a central opening 34. The mixing element shown in Figures 15 and 15A is similar to that shown in Figure 12 with channels 70 whose side faces 71 are inclined at an angle towards the axis of the mixing element of so that the axial movement of the element within the container of the liquid medicament causes a rotation of the element about its axis. The number of channels and their angle of inclination may vary. Figures 16 and 17 show arrangements that induce turbulence at the center of a mixing element. In those embodiments, the mixing elements comprise internal and external coaxial tubular members 80 and 81 connected by means of the angularly spaced blades 82. In Figure 16, two sets of blades are shown, one set being both axially and radially displaced from the other. . The vanes 82 can be arranged so that their planes are parallel to the axis of the tubes 80 and 81, or if it is desired to induce a rotary movement to the elements as they pass through the container, they can be placed at an angle towards this, in propellant form. To increase the turbulence in the liquid medicament as the element passes, the vanes 82 in each set as shown in Figure 16 can be placed at an angle towards those in the other set, for example at an equal angle but opposite the axis of the tubes 80 and 81. It is desirable that the medicament suspension be homogenized to an acceptable degree by the minimum number of passages through the mixing element along the length of the container, for example, by tilting or by reversing movement from end to end of the container. Ideally, one or two tilting movements would be required: that is, if the cartridge has been stored in a horizontal position, it is desirable that a single inclination in a 45 ° direction, accompd by a complete passage of the mixing element in a direction, produce an acceptable homogeneous suspension, or, failing that, a second complete step reversing the inclination of the container through 90 ° is sufficient. The desirability of this facility is to bring the suspension to homogeneity is that patients or users who inadvertently forget to follow the instructions to invest the cartridge / pen a set number of times may, in any case by its handling of the device and preparation to use it by example, simply removing the device from a pocket, handbag or carrying case and placing it for injection, for example, in a sufficiently executed, hermetic tilt and similar handling movements with the device to produce an acceptable level of homogeneity to be achieved in the suspension. The following Comparative Examples illustrate the ease with which insulin crystal suspensions can be homogenized using containers according to the present invention, in relation to prior art containers employing simple spherical mixing elements.
COMPARATIVE EXAMPLE 1In this example, the commercially available 3 ml cartridges of Basal-H-Insulin 100 (suspension) from Hoechst AG were used for use with the Opti-Pen, each holding a standard size of 6.5 cm in length and a diameter internal 9.5 mm. Half of the cartridges were tested as they were commercially supplied, that is, they contained conventional mixing elements in the form of three spheres of stainless steel, each sphere had a diameter of 2.0 mm. The other half was modified by removing the steel spheres and replacing them by a single mixing element according to the present invention, made of sintered glass, with a shape according to the elements shown in Figures 7 and 7A, with a total diameter of 9.0 mm, axial length (thickness) of 4.5 mm, diameter of the central opening of 3.0 mm, and in each of which the four grooves or channels that extend axially peripheral had a width of 1.0 mm and a depth of 1.0 mm. In each of the following tests, 3 cartridge samples from each set were used.
Try theIn this first test, the cartridges were stored for 12 hours in a vertical position, ie vertically with the exit necks in the uppermost part. After this storage, each cartridge was carefully transferred, still maintaining the storage orientation, to an electronically controlled test machine and adjusted to invert each of the cartridges up to 180 ° for a period of 1.5 seconds, and to repeat that action until be stopped. The degree of homogenization was visually verified and evaluated on a per cent basis and the number of investments was noted.
Test 2aIn this second test the procedure of Test 1 above was followed, except that the cartridges were stored and transferred carefully to the test machine in inverted orientation ie vertically with their exit necks in the lower part. Again, the degree of homogenization was evaluated and the number of investments was noted.
Test 3aIn this third test, each of the cartridges were stored for 12 hours in the horizontal position, then the test machine was carefully transferred to that position. In this test the machine was controlled to tilt each cartridge to an angle of 45 ° (for 0.8 seconds), then it was returned to the horizontal (0.8 seconds) and then to a position at 45 ° from the horizontal in the opposite direction (0.8 seconds). Again, this action was repeated, the visual evaluation of the degree of homogenization was made, and the number of inclinations was noted (at an angle of 45 ° and again to the horizontal it is a single inclination).
Test 4aIn this fourth test the procedure in Test 3 above was repeated, except that the machine was programmed to tilt each cartridge from the horizontal to an angle of 90 ° (for 15 seconds), again to horizontal (1.5 seconds), and then up to 90 ° (1.5 seconds) in the opposite direction of the first movement. The machine repeated this action until it was stopped and again the degree of homogenization was evaluated and the number of inclinations was noted (a movement of 90 ° and again towards the horizontal is a single inclination). The results of these tests are shown in the following Table 1.
TABLE 1Number of DegreeInvestment Element No. / HomogenizationTEST Mixed Inclinings Average CartridgeSteel spheres 20 Incomplete. of 3 x 2.00 mm maximum 50% the Complete Element. 100% invention 2a Steel spheres 20 Incomplete. of 3 x 2.00 mm maximum 50%2nd Complete Element. 100% invention 3a Steel spheres 20 Incomplete. of 3 x 2.00 mm maximum 40%3rd Complete Element. 100% invention 4a Steel spheres 20 Incomplete. of 3 x 2.00 mm maximum 50%4th Complete Element. 100% invention COMPARATIVE EXAMPLE 2In this Example, commercially available Insulin Protamin HM Penfil (suspension) filling cartridges from Novo Nordisk, again 6.5 cm in standard length 9.5 mm in internal diameter, were used. Half were tested as they were commercially supplied, i.e. they contained a conventional mixing element in the form of a glass bead having a diameter of 2.5 mm, and the other half was modified by removing the glass loss and replacing it with an element of glass. mixed according to the invention in accordance as illustrated in Comparative Example 1, above.
Subsequently, tests Ib up to 4b were carried out in an identical manner to the tests up to the previous 4th, again 3 cartridges were used in each batch tested, and again the average degree of homogenization was visually evaluated and the number of samples was taken into account. investments / inclinations. The results are shown in the following Table 2.
TABLE 2Degree Number ofInvestment Element No. / HomogenizationTEST Mixed Inclinings Average CartridgeIb Glass beads 20 Incomplete. 1 x 2.5 mm maximum 50-60%Ib Complete Element. 100% invention 2b Glass beads 20 Incomplete. 1 x 2.5 mm maximum 50-60%2b Complete Element. 100% invention 3b Glass beads 20 Incomplete. 1 x 2.5 mm maximum 50-60%3b Complete element. 100% invention 4b Glass beads 20 Incomplete. 1 x 2.5 mm maximum 50-60%4b Complete Element. 100% invention It is noted that in relation to this date, the best method known by the applicant to carry out the aforementioned invention is the one conventional for the manufacture of the objects to which it refers. Having described the invention as above, the content of the following is claimed as property:

Claims (22)

MX9602029A1995-06-021996-05-29Containers for liquid medicaments.MX9602029A (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
GB9511169.61995-06-02
GBGB9511169.6AGB9511169D0 (en)1995-06-021995-06-02Containers for liquid medicaments

Publications (2)

Publication NumberPublication Date
MXPA96002029Atrue MXPA96002029A (en)1997-08-01
MX9602029A MX9602029A (en)1997-08-30

Family

ID=10775402

Family Applications (1)

Application NumberTitlePriority DateFiling Date
MX9602029AMX9602029A (en)1995-06-021996-05-29Containers for liquid medicaments.

Country Status (12)

CountryLink
US (1)US5725500A (en)
EP (1)EP0745369B1 (en)
JP (1)JP3816149B2 (en)
AT (1)ATE213146T1 (en)
CA (1)CA2177543C (en)
DE (1)DE69619159T2 (en)
DK (1)DK0745369T3 (en)
ES (1)ES2168439T3 (en)
GB (1)GB9511169D0 (en)
MX (1)MX9602029A (en)
PT (1)PT745369E (en)
SI (1)SI0745369T1 (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9812070D0 (en)*1998-06-041998-08-05Benoist Girard & CiePlugging and centralising device for locating the stem of a prosthesis
AU4492800A (en)*1999-04-302000-12-12Eli Lilly And CompanyCartridge assembly for medicament suspensions
US6554792B2 (en)1999-05-212003-04-29Mallinckrodt Inc.Suspension device and method
US6357907B1 (en)*1999-06-152002-03-19V & P Scientific, Inc.Magnetic levitation stirring devices and machines for mixing in vessels
US6379032B1 (en)2000-02-182002-04-30Steve SorensenFlow-through agitator
EP1292381B1 (en)*2000-05-032009-07-15D'SILVA, JoeProcess and device for producing liquid dosage formulations
US20030100883A1 (en)*2001-08-312003-05-29Kristensen Lars ThougaardCartridge for liquid insulin
CA2457943A1 (en)*2001-08-312003-03-06Novo-Nordisk A/SA cartridge for liquid insulin
US20030163084A1 (en)*2001-12-202003-08-28Klaus TiemannCreation and agitation of multi-component fluids in injection systems
GB2384527B (en)*2002-01-232004-07-14Bespak PlcDispensing device
US20050215954A1 (en)*2004-03-292005-09-29Mallinckrodt Inc.Apparatus and method for maintaining suspendible agents in suspension
US20080161756A1 (en)*2005-05-032008-07-03Novo Nordisk A/SCartridge Containing a Medicament Suspension and Mixing Elements Having Different Densities
GB0513581D0 (en)2005-07-012005-08-10Norton Healthcare LtdContainer
EP2010249A2 (en)*2006-04-042009-01-07Vnus Medical Technologies, Inc.Method and apparatus for generating vascular treatment foam
US7547300B2 (en)2006-04-122009-06-16Icu Medical, Inc.Vial adaptor for regulating pressure
EP2012856B1 (en)*2006-04-212010-09-08Arzneimittel GmbH Apotheker Vetter & Co. RavensburgSyringe cylinder
CA2662052C (en)*2006-08-312015-11-03Meridian Medical Technologies, Inc.Vortex feature for drug delivery system
US7883499B2 (en)*2007-03-092011-02-08Icu Medical, Inc.Vial adaptors and vials for regulating pressure
BRPI0817907B8 (en)2007-10-022021-06-22Lamodel Ltd apparatus for administering a substance to an individual
JP5203979B2 (en)*2008-02-062013-06-05株式会社東芝 Automatic analyzer
ATE528068T1 (en)*2008-02-282011-10-15Medmix Systems Ag SINGLE CHAMBER DEVICE FOR RECEIVING AND OUTPUTING COMPONENTS
FR2928552B1 (en)*2008-03-112012-01-20Sedat SYRINGE, IN PARTICULAR ANGIOGRAPHIC
WO2010022095A1 (en)2008-08-202010-02-25Icu Medical, Inc.Anti-reflux vial adaptors
EP2158927A1 (en)*2008-08-252010-03-03Debiotech S.A.Drug delivery device with a module for preventing fibrillation downstream of its reservoir
USD702834S1 (en)*2011-03-222014-04-15Medimop Medical Projects Ltd.Cartridge for use in injection device
FR2973664B1 (en)2011-04-082014-02-07Cinqpats MASCARA COMPOSITION CONTAINER / APPLICATOR ASSEMBLY.
CA3176437A1 (en)2011-08-182013-02-21Icu Medical, Inc.Pressure-regulating vial adaptors
CA2852090C (en)*2011-10-202016-05-24Becton, Dickinson And CompanyMixing element for container assemblies
DK2802377T3 (en)2012-01-132017-03-20Icu Medical Inc Pressure regulating bottle adapter and method
US9751056B2 (en)2012-01-232017-09-05Merit Medical Systems, Inc.Mixing syringe
US8834449B2 (en)2012-01-232014-09-16Ikomed Technologies, Inc.Mixing syringe
DE102012202146A1 (en)*2012-02-132013-08-14Bayerische Motoren Werke Aktiengesellschaft Storage tank of cryogenic compressed gas with a storage volume
US10207053B2 (en)*2012-03-162019-02-19Becton, Dickinson And CompanyDrug delivery device for drug suspensions
AU2013204180B2 (en)2012-03-222016-07-21Icu Medical, Inc.Pressure-regulating vial adaptors
DE102012008815B4 (en)*2012-05-072014-03-06Heraeus Medical Gmbh Mixing device for multi-component systems
USD675872S1 (en)2012-06-052013-02-12Medport LlcHand-held mixer agitator
ES2739291T3 (en)2013-01-232020-01-30Icu Medical Inc Pressure regulation vial adapters
US9089475B2 (en)2013-01-232015-07-28Icu Medical, Inc.Pressure-regulating vial adaptors
US9555379B2 (en)2013-03-132017-01-31Bayer Healthcare LlcFluid path set with turbulent mixing chamber, backflow compensator
WO2014145906A2 (en)2013-03-152014-09-18Phd Preventative Health Care And Diagnostics, Inc.A prefilled medication device, method of making and using the same
CA3179530A1 (en)2013-07-192015-01-22Icu Medical, Inc.Pressure-regulating fluid transfer systems and methods
ES2759975T3 (en)*2013-09-062020-05-12Terumo Corp Outer tube of syringe and mold for injection molding
WO2015103603A1 (en)*2014-01-062015-07-09Omni International, Inc.Homogenization tubes with flow disrupters for beadless interrupted flow
WO2015195844A1 (en)2014-06-202015-12-23Icu Medical, Inc.Pressure-regulating vial adaptors
USD959695S1 (en)*2015-04-012022-08-02Novartis AgContainer for pharmaceuticals
USD776482S1 (en)*2015-05-152017-01-17Ningbo Tianqi Molding Co., Ltd.Churning ball
USD776478S1 (en)*2015-08-052017-01-17Cotapaxi Custom Designs and Manufacturing, LLCMixing ball
US10576207B2 (en)2015-10-092020-03-03West Pharma. Services IL, Ltd.Angled syringe patch injector
US11318254B2 (en)2015-10-092022-05-03West Pharma. Services IL, Ltd.Injector needle cap remover
EP3711793B1 (en)2016-01-212021-12-01West Pharma Services IL, Ltd.A method of connecting a cartridge to an automatic injector
JP6885960B2 (en)2016-01-212021-06-16ウェスト ファーマ サービシーズ イスラエル リミテッド Drug delivery device with visual indicators
US10646643B2 (en)2016-01-212020-05-12West Pharma. Services IL, Ltd.Needle insertion and retraction mechanism
EP3397231B1 (en)2016-01-292022-03-02ICU Medical, Inc.Pressure-regulating vial adaptors
US10898638B2 (en)2016-03-032021-01-26Bayer Healthcare LlcSystem and method for improved fluid delivery in multi-fluid injector systems
US11389597B2 (en)2016-03-162022-07-19West Pharma. Services IL, Ltd.Staged telescopic screw assembly having different visual indicators
WO2017213783A1 (en)*2016-06-072017-12-14Mayo Foundation For Medical Education And ResearchSelf-stirring syringe devices and systems
US11338090B2 (en)2016-08-012022-05-24West Pharma. Services IL, Ltd.Anti-rotation cartridge pin
JP7059251B2 (en)2016-08-012022-04-25ウェスト ファーマ サービシーズ イスラエル リミテッド A spring that prevents the door from closing halfway
CA3037577A1 (en)2016-09-302018-04-05Icu Medical, Inc.Pressure-regulating vial access devices and methods
US12263326B2 (en)2016-11-142025-04-01Bayer Healthcare LlcMethods and systems for verifying the contents of a syringe used for medical fluid delivery
DE102017202607A1 (en)*2017-02-172018-08-23Vetter Pharma-Fertigung GmbH & Co. KG Drug container for storing and providing at least two medicament substances which can be mixed with one another and methods for operating such a medicament container
CN106955236B (en)*2017-05-092019-11-22李爱华 Easy Dispensing Syringe
EP3630226A1 (en)2017-05-302020-04-08West Pharma. Services Il, Ltd.Modular drive train for wearable injector
CA3104738A1 (en)2017-06-282019-01-03University Of TasmaniaLiquid-liquid mixing device suitable for sample preparation by liquid-liquid extraction
AU2018326386B2 (en)2017-08-312024-03-28Bayer Healthcare LlcFluid injector system volume compensation system and method
EP3675931B1 (en)2017-08-312021-08-11Bayer Healthcare LLCInjector pressure calibration system and method
EP3676854A1 (en)2017-08-312020-07-08Bayer Healthcare LLCFluid path impedance assessment for improving fluid delivery performance
WO2019046261A1 (en)2017-08-312019-03-07Bayer Healthcare LlcSystem and method for drive member position and fluid injector system mechanical calibration
JP7493337B2 (en)2017-08-312024-05-31バイエル・ヘルスケア・エルエルシー Method for dynamic pressure control in a fluid injector system - Patents.com
EP3781233B1 (en)2018-04-192025-09-17Bayer Healthcare LLCSystem and method for air detection in fluid injector
DE102018210941A1 (en)*2018-07-032020-01-09Vetter Pharma-Fertigung GmbH & Co. KG Stopper device, medication container and method for mixing two substances in a medication container
CA3111209A1 (en)2018-08-282020-03-05Bayer Healthcare LlcFluid injector system with improved ratio performance
JP7450608B2 (en)2018-08-282024-03-15バイエル・ヘルスケア・エルエルシー Fluid injector system, method for preventing fluid backflow, and computer program product
WO2020082150A1 (en)*2018-10-262020-04-30Universidade Estadual De CampinasLocal anaesthetic application device
US20200269238A1 (en)*2019-02-222020-08-27Perkinelmer Health Sciences, Inc.Probes and liquid handling systems and methods including the same
CR20220394A (en)2020-02-212023-01-23Bayer Healthcare LlcFluid path connectors for medical fluid delivery
PT4110452T (en)2020-02-282025-01-14Bayer Healthcare Llc FLUID MIXING SET
WO2021188460A1 (en)2020-03-162021-09-23Bayer Healthcare LlcStopcock apparatus for angiography injector fluid paths
CN115697435A (en)2020-06-182023-02-03拜耳医药保健有限责任公司 Inline Bubble Suspension Device for the Fluid Path of Angiography Injectors
RS66861B1 (en)2020-08-112025-06-30Bayer Healthcare LlcFeatures for angiography syringe
CN116547022A (en)2020-12-012023-08-04拜耳医药保健有限责任公司Cassette for holding fluid path components of a fluid injector system
EP4059592B1 (en)*2021-03-162025-09-10Swissmeca SASample tube and method for dispersing and homogenizing
WO2022265695A1 (en)2021-06-172022-12-22Bayer Healthcare LlcSystem and method for detecting fluid type in tubing for fluid injector apparatus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DE235691C (en)*1909-07-171911-06-21
US3738760A (en)*1971-10-131973-06-12Plastic Kote CoPaint touch-up container
EP0013721B1 (en)*1979-01-301981-12-16Kurt Vogelsang GmbHMixing device for cylindrical containers filled with paint or lacquer
US4568335A (en)*1981-08-281986-02-04Markwell Medical Institute, Inc.Device for the controlled infusion of medications
DE3606163A1 (en)*1986-02-261987-08-27Hoechst Ag DEVICE FOR APPLICATING MEDICAL SUSPENSIONS
US5246670A (en)*1992-09-231993-09-21Habley Medical Technology CorporationPharmaceutical mixing container with buoyant mixing element
US5352036A (en)*1992-09-231994-10-04Habley Medical Technology CorporationMethod for mixing and dispensing a liquid pharmaceutical with a miscible component
US5489266A (en)*1994-01-251996-02-06Becton, Dickinson And CompanySyringe assembly and method for lyophilizing and reconstituting injectable medication
US5603695A (en)*1995-06-071997-02-18Erickson; KimDevice for alkalizing local anesthetic injection medication

Similar Documents

PublicationPublication DateTitle
MXPA96002029A (en)Containers for liqui medicines
CA2177543C (en)Containers for liquid medicaments
CA1275976C (en)Device for the administration of medicament suspensions
US5549574A (en)Cartridge assembly for use in a pen-type medicament injector
US7789853B2 (en)Infusion apparatus with constant force spring energy source
FI92467B (en) Method and apparatus for injection
CN102958550B (en)Cartridge case retainer and alignment interface
ES2773263T3 (en) Mixing element for packaging sets
WO1995009017A1 (en)Fluid delivery apparatus
US5220948A (en)Precision syringe-filling mechanism
JP7079843B2 (en) Drug mixer
US20080161756A1 (en)Cartridge Containing a Medicament Suspension and Mixing Elements Having Different Densities
JP7125025B2 (en) drug mixing device
ES2861508T3 (en) Drug mixing device
JP2022081502A (en)Drug mixing device
CA2065814A1 (en)Dispenser device
EP4483936A1 (en)Device for mixing a main liquid medical substance with a secondary substance and related mixing system
US20070260212A1 (en)Ampules for Small Unit Dose Volumes of Drug
WO2000071191A2 (en)Cartridge assembly for medicament suspensions
JP2022084637A (en)Medicine mixing device
JP2022084643A (en)Drug mixing device
WO2024141552A1 (en)Drug mixing system
JPH05111524A (en)Medical kit product
BR102018072203B1 (en) LOCAL ANESTHESIA APPLICATION DEVICE

[8]ページ先頭

©2009-2025 Movatter.jp